Skip to main content
Top
Published in: Tumor Biology 4/2013

01-08-2013 | Research Article

Mitochondrial D310 instability in Asian Indian breast cancer patients

Authors: Mohammed A. Alhomidi, Bhavani Vedicherla, Sireesha Movva, Prabhakar K. Rao, Yog R. Ahuja, Qurratulain Hasan

Published in: Tumor Biology | Issue 4/2013

Login to get access

Abstract

Somatic mutations in mitochondrial DNA (mtDNA) have been demonstrated in various tumors. Mitochondrial D-loop is a non-coding region in the mitochondrial genome, which has essential transcription and replication elements, and alterations in this region may affect both these processes. The D-loop has a poly-C tract (PCT) located between 303 and 315 nucleotides known as D310, which has been identified as a frequent hot spot mutation region in human neoplasia. In the present study, 77 pairs of breast tumor and adjacent non-tumorous tissue samples were analyzed by polymerase chain reaction–single-strand conformational polymorphism, restriction fragment length polymorphism, and sequencing to evaluate the frequency of D310 (PCT) mutations and its association with clinicopathologic parameters of breast cancer. Alterations were detected in 25 of 77 (32.5 %) breast cancer samples; these included 7/25 (28 %) cases with heteroplasmy. This is the first study from Asian Indian breast cancer (BC) patients indicating a relatively high frequency of D310 mutations, suggesting that mtDNA instability at D310 may be a common characteristic of BC. However, 66.7 % of the alterations were observed in stage II BC, indicating that this may be a more important change for early progression of the disease rather than its initiation.
Literature
1.
go back to reference Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Childhood. 2004;4:5. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Childhood. 2004;4:5.
2.
go back to reference Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010;2285–92. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010;2285–92.
3.
4.
go back to reference Levi F, Lucchini F, Negri E, La Vecchia C. Continuing declines in cancer mortality in the European Union. Ann Oncol. 2007;18(3):593.PubMedCrossRef Levi F, Lucchini F, Negri E, La Vecchia C. Continuing declines in cancer mortality in the European Union. Ann Oncol. 2007;18(3):593.PubMedCrossRef
5.
go back to reference Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Ann Rev Public health. 1996;17(1):47–67.CrossRef Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Ann Rev Public health. 1996;17(1):47–67.CrossRef
6.
go back to reference Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer. 2009;125(7):1663–70.PubMedCrossRef Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer. 2009;125(7):1663–70.PubMedCrossRef
7.
go back to reference Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, et al. Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst. 1993;85(22):1819.PubMedCrossRef Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, et al. Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst. 1993;85(22):1819.PubMedCrossRef
8.
9.
go back to reference Anderson S, Bankier A, Barrell BG, De Bruijn M, Coulson A, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–65.PubMedCrossRef Anderson S, Bankier A, Barrell BG, De Bruijn M, Coulson A, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–65.PubMedCrossRef
10.
go back to reference Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol. 2001;2(1):67–71.PubMedCrossRef Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol. 2001;2(1):67–71.PubMedCrossRef
11.
go back to reference Ye C, Shu XO, Pierce L, Wen W, Courtney R, Gao YT, et al. Mutations in the mitochondrial DNA D-loop region and breast cancer risk. Breast Cancer Res Treat. 2010;119(2):431–6.PubMedCrossRef Ye C, Shu XO, Pierce L, Wen W, Courtney R, Gao YT, et al. Mutations in the mitochondrial DNA D-loop region and breast cancer risk. Breast Cancer Res Treat. 2010;119(2):431–6.PubMedCrossRef
12.
go back to reference Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC. Anti-and pro-tumor functions of autophagy. Biochim Biophys Acta. 2009;1793(9):1524–32.PubMedCrossRef Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC. Anti-and pro-tumor functions of autophagy. Biochim Biophys Acta. 2009;1793(9):1524–32.PubMedCrossRef
13.
14.
go back to reference Bianchi NO, Bianchi MS, Richard SM. Mitochondrial genome instability in human cancers. Mutat Res Rev Mutat Res. 2001;488(1):9–23.CrossRef Bianchi NO, Bianchi MS, Richard SM. Mitochondrial genome instability in human cancers. Mutat Res Rev Mutat Res. 2001;488(1):9–23.CrossRef
15.
go back to reference Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and human cancer. Curr Mol Med. 2007;7(1):121–31.PubMedCrossRef Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and human cancer. Curr Mol Med. 2007;7(1):121–31.PubMedCrossRef
16.
go back to reference Lee HC, Yin PH, Lin JINC, Wu CC, Chen CYI, Wu CWUN, et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci. 2005;1042(1):109–22.PubMedCrossRef Lee HC, Yin PH, Lin JINC, Wu CC, Chen CYI, Wu CWUN, et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci. 2005;1042(1):109–22.PubMedCrossRef
17.
go back to reference Suzuki M, Toyooka S, Miyajima K, Iizasa T, Fujisawa T, Bekele NB, et al. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res. 2003;9(15):5636.PubMed Suzuki M, Toyooka S, Miyajima K, Iizasa T, Fujisawa T, Bekele NB, et al. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res. 2003;9(15):5636.PubMed
18.
go back to reference Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 2001;61(19):7015.PubMed Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 2001;61(19):7015.PubMed
19.
go back to reference Vasavi M, Ponnala S, Gujjari K, Boddu P, Bharatula RS, Prasad R, et al. DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status. Tumori. 2006;92(2):155.PubMed Vasavi M, Ponnala S, Gujjari K, Boddu P, Bharatula RS, Prasad R, et al. DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status. Tumori. 2006;92(2):155.PubMed
20.
go back to reference Bassam BJ, Caetano-Anollés G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 1991;196(1):80–3.PubMedCrossRef Bassam BJ, Caetano-Anollés G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 1991;196(1):80–3.PubMedCrossRef
21.
go back to reference Modica-Napolitano JS, Singh K. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med. 2002;2(1):1–19.CrossRef Modica-Napolitano JS, Singh K. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med. 2002;2(1):1–19.CrossRef
22.
go back to reference Lee HC, Wei YH. Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci. 2009;10(2):674–701.PubMedCrossRef Lee HC, Wei YH. Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci. 2009;10(2):674–701.PubMedCrossRef
23.
go back to reference Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 2001;61(20):7623.PubMed Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 2001;61(20):7623.PubMed
24.
go back to reference Tan DJ, Bai RK, Wong LJC. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002;62(4):972–6.PubMed Tan DJ, Bai RK, Wong LJC. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002;62(4):972–6.PubMed
25.
go back to reference Lu J, Sharma LK, Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009;19(7):802–15.PubMedCrossRef Lu J, Sharma LK, Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009;19(7):802–15.PubMedCrossRef
26.
go back to reference Richard SM, Bailliet G, Páez GL, Bianchi MS, Peltomäki P, Bianchi NO. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000;60(15):4231.PubMed Richard SM, Bailliet G, Páez GL, Bianchi MS, Peltomäki P, Bianchi NO. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000;60(15):4231.PubMed
27.
28.
go back to reference Salas A, Yao YG, Macaulay V, Vega A, Carracedo Á, Bandelt HJ. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. 2005;2(11):e296.PubMedCrossRef Salas A, Yao YG, Macaulay V, Vega A, Carracedo Á, Bandelt HJ. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. 2005;2(11):e296.PubMedCrossRef
29.
go back to reference Mithani SK, Taube JM, Zhou S, Smith IM, Koch WM, Westra WH, et al. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer. Clin Cancer Res. 2007;13(15):4331.PubMedCrossRef Mithani SK, Taube JM, Zhou S, Smith IM, Koch WM, Westra WH, et al. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer. Clin Cancer Res. 2007;13(15):4331.PubMedCrossRef
30.
go back to reference Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008;320(5876):661.PubMedCrossRef Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008;320(5876):661.PubMedCrossRef
31.
go back to reference Lièvre A, Chapusot C, Bouvier AM, Zinzindohoué F, Piard F, Roignot P, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol. 2005;23(15):3517–25.PubMedCrossRef Lièvre A, Chapusot C, Bouvier AM, Zinzindohoué F, Piard F, Roignot P, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol. 2005;23(15):3517–25.PubMedCrossRef
32.
go back to reference Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, et al. Mitochondrial DNA G10398A variant is not associated with breast cancer in African–American women. Cancer Genet Cytogenet. 2008;181(1):16–9.PubMedCrossRef Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, et al. Mitochondrial DNA G10398A variant is not associated with breast cancer in African–American women. Cancer Genet Cytogenet. 2008;181(1):16–9.PubMedCrossRef
Metadata
Title
Mitochondrial D310 instability in Asian Indian breast cancer patients
Authors
Mohammed A. Alhomidi
Bhavani Vedicherla
Sireesha Movva
Prabhakar K. Rao
Yog R. Ahuja
Qurratulain Hasan
Publication date
01-08-2013
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2013
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0793-0

Other articles of this Issue 4/2013

Tumor Biology 4/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine